ICOS: Added Heart Protection with NLA & AHA-Recommended Dyslipidemia Therapy

Know More and ICOS Banner


is recommended by the American Heart Association and the National lipid Association

Improve CV outcomes in your patients

learn more

About AHA & NLA Recommendations

GGI-CO-A1-AQS-300040480-ELC-H24-1443
IPE: Icosapent ethyl, AHA: American Heart Association (AHA) Science Advisory 2020, NLA: National Lipid Association (NLA) Scientific Statement 2019, T2DM: Type 2 diabetes, CAD: Coronary Artery Disease
As per prescribing information of ICOS generated & latest modified on June 23
For the use of a Registered Medical Practitioner, Hospital or Laboratory only.
All content including: text, images, audio, or other formats were created for medical educational purposes only. Offerings for continuing education are clearly identified and the appropriate target audience is identified. This communication is restricted for the use of HCPs and must not be shared in public domain. The opinions expressed in this video are solely the views of the speaker. The presentation may contain off label usage of drug(s) aimed at educational purpose only. Dr. Reddy’s Laboratories Ltd including but not limited its Affiliates strictly does not recommend any off label usage of its marketing products. Prior to treatment kindly refer to the latest prescribing information approved by the local authorities. No part of this content may be used, reproduced, transmitted or stored in any form without the written permission of Dr. Reddy’s.